everolimus
novartis
[]
 despite an increase in pfs, everolimus has an orr of only 5% in pnets. can we do better? happy to present this bench-to-bedside collaboration on pnets between and the lab of #gi23 come chat at poster g18 or read thread below 
Hem/Onc fellow at @karmanoscancer. Alum @AlbanyMed
 @mcgillu. AΩA. H&N and Sarcoma theMednet Associate Editor.